Prevalence of proteinuria in rural adult population in Tamil Nadu

Indian Journal of Medical Research

Volumn 124, Issue 2, 2006, Pages 185-188

  Ahmed, Isthiaque ^a   John, George T ^a   Kirubakaran, Meshach G ^a   Jacob, Chakko K ^a   Muliyil, Jayaprakash ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Albuminuria; Dipstick; Endstage renal disease; Proteinuria

Indexed keywords

ALBUMIN; PLASMA PROTEIN; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANAMNESIS; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; ECHOGRAPHY; FEMALE; GLOMERULOSCLEROSIS; HUMAN; INDIA; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; PROTEINURIA; RURAL AREA; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA; RURAL HEALTH;

EID: 33749500733     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Abuelo JG. Proteinuria: diagnostic principles and procedures. Ann Intern Med 1983; 98: 186-91.
2. Berggard I. Plasma proteins in normal human urine. In: Manuarl Y, Revellard JP, Betuel H, editors. Proteins in normal and pathological urine. 1st ed. University Basle and New York: S. Karger; 1970 p. 111-4.
3. Grant GH. The proteins of normal urine. J Clin Pathol 1959; 12: 510-7.
4. Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286: 421-6.
5. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-36.
6. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end stage renal disease in a cohort of mass screening. KI 1996; 49: 800-5.
7. Lindholm LH, Ibsen H, Dahlof B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint Reduction in Hypertension Study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 1004-10.
8. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73-87.
9. Agodoa LY, Appel L, Bakris GL, et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-28.
10. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-60.
11. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-9.